TGFA and hepatocellular carcinoma: In vitro, it promoted proliferation of human hepatoma cells by activation of the MAPK/ERK pathway through upregulation of TGF-α transcription via nuclear factor “kappa-light-chain-enhancer” of activated B-cells (NF-κB) [135].